Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rozencweig

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1977
Cytembena: an anticancer drug with an unique structureD D Von Hoff, M Rozencweig, F M Muggia
Oncology (Williston Park, N.Y.)|July 1, 1987
Clinical status of carboplatinR Canetta, C Franks, L Smaldone, et al.
Medical and Pediatric Oncology|January 1, 1976
Overview of early and investigational chemotherapeutic agents in solid tumorsM Rozencweig, M Slavik, F M Muggia, et al.
Journal of Chronic Diseases|January 1, 1981
Methodology for the assessment of new dichotomous diagnostic testsM Staquet, M Rozencweig, Y J Lee, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1985
Phase I-II evaluation of carminomycin in adults with acute leukemiaL Debusscher, M Malarme, D Bron, et al.
JAMA|April 18, 1977
Adjuvant chemotherapy: correct adviceA Louie, D D Von Hoff, M Rozencweig, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trialH Bleiberg, B Gerard, O Dalesio, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|September 8, 1983
[Phase I study of alizapride in cancer patients treated with cisplatin]C Nicaise, M Rozencweig, M Ortmans, et al.
The Journal of Urology|April 1, 1977
Estramustine phosphate: a specific chemotherapeutic agent?D D Von Hoff, M Rozencweig, M Slavik, et al.
Cancer Treatment Reports|September 1, 1983
Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategyM J Staquet, D P Byar, S B Green, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1977
Cytembena: an anticancer drug with an unique structureD D Von Hoff, M Rozencweig, F M Muggia
Oncology (Williston Park, N.Y.)|July 1, 1987
Clinical status of carboplatinR Canetta, C Franks, L Smaldone, et al.
Medical and Pediatric Oncology|January 1, 1976
Overview of early and investigational chemotherapeutic agents in solid tumorsM Rozencweig, M Slavik, F M Muggia, et al.
Journal of Chronic Diseases|January 1, 1981
Methodology for the assessment of new dichotomous diagnostic testsM Staquet, M Rozencweig, Y J Lee, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1985
Phase I-II evaluation of carminomycin in adults with acute leukemiaL Debusscher, M Malarme, D Bron, et al.
JAMA|April 18, 1977
Adjuvant chemotherapy: correct adviceA Louie, D D Von Hoff, M Rozencweig, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trialH Bleiberg, B Gerard, O Dalesio, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|September 8, 1983
[Phase I study of alizapride in cancer patients treated with cisplatin]C Nicaise, M Rozencweig, M Ortmans, et al.
The Journal of Urology|April 1, 1977
Estramustine phosphate: a specific chemotherapeutic agent?D D Von Hoff, M Rozencweig, M Slavik, et al.
Cancer Treatment Reports|September 1, 1983
Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategyM J Staquet, D P Byar, S B Green, et al.
Pageof 15